CCG (HRG included)
Approval is for 172 and 87 micrograms strengths.
Restriction: Maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year
Reason for decision:
Suitable for initiation in primary care in line with restrictions